Goldilocks and the three bonds: new evidence for the conditional benefits of dietary α-linolenic acid in treating cardiovascular risk in the metabolic syndrome.
Department of Nutrition and Metabolism, Faculty of Health and Medical Sciences, University of Surrey, Guildford, Surrey, UK. b.griffin@surrey.ac.uk
Bruce A
BA
Griffin
D029741:Brassica rapa / Q000737:chemistry*; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D004038:Diet, Reducing; D005229:Fatty Acids, Monounsaturated; D005260:Female; D006801:Humans; D008297:Male; D024821:Metabolic Syndrome / Q000178:diet therapy*; D010938:Plant Oils / Q000627:therapeutic use*; D000074262:Rapeseed Oil; D015431:Weight Loss; D017962:alpha-Linolenic Acid / Q000627:therapeutic use*
D005229:Fatty Acids, Monounsaturated; D010938:Plant Oils; D000074262:Rapeseed Oil; D017962:alpha-Linolenic Acid